Effect of hypothyroidism on insulin sensitivity and glucose tolerance in dogs. 2012

Natalie Hofer-Inteeworn, and David L Panciera, and William E Monroe, and Korinn E Saker, and Rebecca Hegstad Davies, and Kent R Refsal, and Joseph W Kemnitz
Department of Small Animal Clinical Sciences, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061, USA.

OBJECTIVE To determine the effects of hypothyroidism on insulin sensitivity, glucose tolerance, and concentrations of hormones counter-regulatory to insulin in dogs. METHODS 8 anestrous mixed-breed bitches with experimentally induced hypothyroidism and 8 euthyroid control dogs. METHODS The insulin-modified frequently sampled IV glucose tolerance test and minimal model analysis were used to determine basal plasma insulin and glucose concentrations, acute insulin response to glucose, insulin sensitivity, glucose effectiveness, and disposition index. Growth hormone response was assessed by stimulation and suppression tests. Additionally, basal serum growth hormone (GH) and insulin-like growth factor-1 (IGF-1) concentrations and urine cortisol-to-creatinine concentration ratios were measured and dual energy x-ray absorptiometry was performed to evaluate body composition. RESULTS Insulin sensitivity was lower in the hypothyroid group than in the euthyroid group, whereas acute insulin response to glucose was higher. Glucose effectiveness and disposition index were not different between groups. Basal serum GH and IGF-1 concentrations as well as abdominal fat content were high in hypothyroid dogs, but urine cortisol-to-creatinine concentration ratios were unchanged. CONCLUSIONS Hypothyroidism appeared to negatively affect glucose homeostasis by inducing insulin resistance, but overall glucose tolerance was maintained by increased insulin secretion in hypothyroid dogs. Possible factors affecting insulin sensitivity are high serum GH and IGF-1 concentrations and an increase in abdominal fat. In dogs with diseases involving impaired insulin secretion such as diabetes mellitus, concurrent hypothyroidism can have important clinical implications.

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D004283 Dog Diseases Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used. Canine Diseases,Canine Disease,Disease, Canine,Disease, Dog,Diseases, Canine,Diseases, Dog,Dog Disease
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females

Related Publications

Natalie Hofer-Inteeworn, and David L Panciera, and William E Monroe, and Korinn E Saker, and Rebecca Hegstad Davies, and Kent R Refsal, and Joseph W Kemnitz
June 1970, The Journal of endocrinology,
Natalie Hofer-Inteeworn, and David L Panciera, and William E Monroe, and Korinn E Saker, and Rebecca Hegstad Davies, and Kent R Refsal, and Joseph W Kemnitz
May 1989, Diabetes,
Natalie Hofer-Inteeworn, and David L Panciera, and William E Monroe, and Korinn E Saker, and Rebecca Hegstad Davies, and Kent R Refsal, and Joseph W Kemnitz
January 2011, Bulletin of experimental biology and medicine,
Natalie Hofer-Inteeworn, and David L Panciera, and William E Monroe, and Korinn E Saker, and Rebecca Hegstad Davies, and Kent R Refsal, and Joseph W Kemnitz
June 1972, Diabetes,
Natalie Hofer-Inteeworn, and David L Panciera, and William E Monroe, and Korinn E Saker, and Rebecca Hegstad Davies, and Kent R Refsal, and Joseph W Kemnitz
April 1960, Diseases of the nervous system,
Natalie Hofer-Inteeworn, and David L Panciera, and William E Monroe, and Korinn E Saker, and Rebecca Hegstad Davies, and Kent R Refsal, and Joseph W Kemnitz
August 1969, Clinical science,
Natalie Hofer-Inteeworn, and David L Panciera, and William E Monroe, and Korinn E Saker, and Rebecca Hegstad Davies, and Kent R Refsal, and Joseph W Kemnitz
January 2003, Medicine and science in sports and exercise,
Natalie Hofer-Inteeworn, and David L Panciera, and William E Monroe, and Korinn E Saker, and Rebecca Hegstad Davies, and Kent R Refsal, and Joseph W Kemnitz
October 2010, Domestic animal endocrinology,
Natalie Hofer-Inteeworn, and David L Panciera, and William E Monroe, and Korinn E Saker, and Rebecca Hegstad Davies, and Kent R Refsal, and Joseph W Kemnitz
September 1990, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
Natalie Hofer-Inteeworn, and David L Panciera, and William E Monroe, and Korinn E Saker, and Rebecca Hegstad Davies, and Kent R Refsal, and Joseph W Kemnitz
November 1989, Kidney international. Supplement,
Copied contents to your clipboard!